The study site is the first in Canada, designed for spinal cord injury treatment. Here are five things to know:
1. Michael Fehlings, MD, PhD, is principal investigator at the site. He is director of the spinal program at Toronto Western Hospital at the University Health Network.
2. The INSPIRE study involves InVivo’s Neuro-Spinal Scaffold, designed for patients with acute spinal cord injury. The device is placed inside the decompressed and debrided injury epicenter to support appositional healing.
3. The Neuro-Spinal Scaffold received a Humanitarian Use Device designation and is used at several evaluation sites across the United States.
4. The technology is designed for neural regeneration across the injury. The trial is designed for complete treatment of T2-T12/L1 spinal cord injury.
5. The initial patients in the trial have reported improvement.
More articles on orthopedic devices:
Stryker VP sells 10k company shares: 5 points
Inspired Spine hosts educational conference on MIS spine—4 takeaways
6 key trends in the orthopedic device industry for the next 8 years
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
